Skip to main content

Table 6 Comparison between controlled and uncontrolled patients regarding their clinical parameters

From: Screening for B cell, T cell and natural killer cell defects among children with methylmalonic and propionic acidemias

Variables Controlled Uncontrolled Independent t test
N = 18 N = 12 t/χ2* p value
Age (mo.) Mean ± SD 34.78 ± 23.50 42.67 ± 22.91 0.91 0.371
Range 10–86 6–72
Sex (n (%)) Female 11 (61.1%) 5 (41.7%) 1.094 0.296*
Male 7 (38.9%) 7 (58.3%)
Weight (p) Mean ± SD 21.78 ± 26.20 29.17 ± 29.09 0.724 0.475
Range 3–75 3–75
Height (p) Mean ± SD 6.28 ± 5.63 14.08 ± 23.39 1.369 0.182
Range 3–25 3–75
Age at metabolic disease onset Mean ± SD 6.29 ± 4.65 7.00 ± 4.65 0.407 0.687
Range 0.3–19 0–12
Age of onset of infection (mo.) Mean ± SD 5.72 ± 4.87 6.59 ± 3.83 0.518 0.608
Range 0.03–19 0.1–12
Average duration of antibiotics use at time of infection (days) Mean ± SD 6.00 ± 0.84 5.75 ± 1.06 − 0.721 0.477
Range 4–7 4–7
Frequency of hospitalization
due to infection/year
Once 8 (44.4%) 4 (33.3%) 0.833 0.659*
Twice 6 (33.3%) 6 (50.0%)
Thrice 4 (22.2%) 2 (16.7%)
Average duration of infection (days) Mean ± SD 6.67 ± 1.19 6.50 ± 1.31 − 0.361 0.721
Range 4–8 4–8
  1. mo. months, N number, p percentile, SD standard deviation, % percentage
  2. *Chi-square test